Que significa "Clear"?
O animal non leva a mutación. Non desenvolverá a enfermidade e non o transmitirá.
Can Lipofuscinose ceroide neuronal 10 (NCL10)
The Neuronal Ceroid Lipofuscinosis 10 (NCL10) DNA test in dogs is essential for early detection of this inherited neurodegenerative disorder. NCL10 affects the nervous system, leading to progressive neurological decline and reduced quality of life. By using a simple DNA test, breeders and veterinarians can identify carriers and affected dogs, helping to prevent the spread of this fatal condition. Early diagnosis through the NCL10 DNA test enables better management and informed breeding decisions. This genetic screening is crucial for maintaining healthy dog populations and promoting responsible breeding practices. Ensure your dog’s health with the reliable NCL10 DNA test today. Protect your pets from hereditary diseases with advanced genetic testing.
Abreviatura: NCL10
Mutación analizada: CTSD c.597G>A
Herdanza: Autosómico recesivo
Acrónimo
NCL10
Frecuencia observada
Gravidade clínica
Clasificación clínica
Enfermidades neurolóxicas
Mutación analizada
CTSD c.597G>A
p.(M199I)
p.(M199I)
Modo de herdanza
Autosómico recesivo (Completo)
Resumo da proba:
The DNA test for Neuronal Ceroid Lipofuscinosis 10 (NCL10) in dogs helps identify carriers and affected individuals of this inherited neurodegenerative disorder. NCL10 leads to progressive neurological decline, causing symptoms like vision loss, seizures, and motor dysfunction. Early genetic testing enables breeders to make informed decisions to reduce the incidence of the disease. This test is especially important in breeds known to carry the NCL10 mutation. By using DNA testing, the health and quality of life of future generations can be improved.
Dispoñible no pack: Basic
Esta proba de ADN está incluída a partir do noso paquete Basic — e tamén forma parte dos paquetes Basic, Standard, Advanced, Complete.
Ver paquetes de probas de ADN →Elixe o paquete que mellor se adapta á túa estratexia de reprodución ou saúde dos teus animais.
Understanding Neuronal Ceroid Lipofuscinosis 10 (NCL10) in Dogs
Neuronal Ceroid Lipofuscinosis 10 (NCL10) is a progressive neurodegenerative disorder that affects the central nervous system of dogs. It is classified as a lysosomal storage disease, which means that it results from the accumulation of certain proteins and lipids within the cells, leading to cellular dysfunction and death. This condition is caused by mutations in the CLN5 gene, which plays a crucial role in cellular metabolism and waste processing.
Symptoms of NCL10
The symptoms of NCL10 typically manifest in young dogs, usually between the ages of 6 months and 3 years. Initial signs may include behavioral changes, such as increased anxiety and irritability, as well as problems with coordination and balance. As the disease progresses, dogs may experience vision problems, seizures, and cognitive decline. Eventually, the condition can lead to severe neurological impairment and, ultimately, a decline in quality of life.
Diagnosis of NCL10
Diagnosis of Neuronal Ceroid Lipofuscinosis 10 is primarily based on clinical observation and genetic testing. Veterinarians may suspect NCL10 based on the dog's symptoms and family history. A definitive diagnosis can be made through DNA testing, which identifies mutations in the CLN5 gene associated with this condition. Early diagnosis is crucial for managing the disease and making informed decisions regarding treatment options and care.
Opcións de xestión e tratamento
Currently, there is no cure for Neuronal Ceroid Lipofuscinosis 10, and treatment options are largely supportive. Management focuses on alleviating symptoms and improving the quality of life for affected dogs. This may include physical therapy, dietary adjustments, and medications to manage seizures or other symptoms. Regular veterinary check-ups are essential to monitor the progression of the disease and make necessary adjustments to the care plan.
Importancia das probas xenéticas
Genetic testing for NCL10 is vital for breeders and dog owners to understand the genetic risks associated with this condition. By identifying carrier dogs and affected individuals, responsible breeding practices can be implemented to reduce the incidence of NCL10 in future generations. Additionally, genetic testing can provide valuable information for pet owners regarding the health of their dogs and help in making informed decisions about their care.
Conclusión
Neuronal Ceroid Lipofuscinosis 10 is a serious genetic disorder that poses significant challenges for affected dogs and their owners. Understanding the condition, its symptoms, and the importance of genetic testing can empower pet owners to take proactive steps in managing their dog's health. While there is no cure, early diagnosis and supportive care can help improve the quality of life for dogs suffering from this debilitating disease.
Raza recoñecida para a proba: Lipofuscinose ceroide neuronal 10 (NCL10)
- American Bulldog
- American Bully
🧬 Interpretation of genotypes NCL10
Xenotipo
Estado
🟡 N/N
Non transportista - Sen risco
🟡 N/NCL10
Transportista - Sen risco
❌ NCL10/NCL10
Afectado - En risco
FAQ: entender a interpretación
Un "Carrier" é serio?
Non. O animal é xeralmente san pero pode transmitirlle a mutación descendencia.
E se un animal está "afectado"?
Leva dúas copias mutadas. Espéranse signos clínicos dependendo de a enfermidade. Non se debe criar.
Por que hai diferenzas entre homes e mulleres?
Algunhas enfermidades están ligadas ao sexo, polo que a súa expresión varía dependendo da sexo animal.
Predicir a descendencia
N/N (non-transportista)
N/NCL10 (Transportista)
NCL10/NCL10 (Afectado)
Preguntas frecuentes sobre as probas de ADN
Que detecta esta proba de ADN?
This DNA test detects the mutation associated with Neuronal Ceroid Lipofuscinosis 10 (NCL10) in order to identify clear, carrier, or at-risk animals.
Por que probar un animal de cría?
As probas de ADN axudan aos criadores a planificar apareamentos máis seguros e a reducir o risco de transmitir a mutación á descendencia.
Cal é o modo de herdanza desta proba?
O modo de herdanza informado para esta proba é Autosómico Recesivo.
Que mutación se analiza nesta proba?
This test analyses the mutation CTSD c.597G>A.
Un animal portador está necesariamente afectado?
Non necesariamente. A interpretación depende do patrón de herdanza e do xenotipo resultante.
Referencias
Awano Tomoyuki, Katz Martin L, O'Brien Dennis P, Taylor Jeremy F, Evans Jason, Khan Shahnawaz, Sohar Istvan, Lobel Peter, Johnson Gary S. A mutation in the cathepsin D gene (CTSD) in American Bulldogs with neuronal ceroid lipofuscinosis. Mol Genet Metab. 2006 Apr;87(4):341-8. doi: 10.1016/j.ymgme.2005.11.005. Epub 2006 Jan 4.